After fertilization, zygotes acquire totipotency, the ability to differentiate into any type of cell. Embryos lose this ability during preimplantation development. Over the course of these processes, gene expression patterns and chromatin structures change dynamically [1, 2] . Concomitantly with these changes, epigenetic modifications drastically shift, a change that is at least partially responsible for changes in gene expression and chromatin structure and the loss of totipotency [3] . One of these epigenetic modifications, H3K9me3, has been shown to play important roles in heterochromatin formation and repression of gene expression in various types of cells, including preimplantation embryos [4, 5] . Furthermore, it has been reported that decreasing the level of H3K9me3 improves the efficiency of reprogramming in somatic cell nuclei transferred to enucleated oocytes, suggesting that H3K9me3 is one of the determinants of embryo plasticity [6] . Although the functions of H3K9me3 in preimplantation embryos have been thoroughly investigated, the mechanisms by which this epigenetic modification is regulated are not well understood.
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A recent paper published in EMBO Journal, by Heng-Yu Fan's laboratory [7] reported that DCAF13, an adaptor of CRL4 ubiquitin E3 ligase, is involved in the regulation of H3K9me3 in preimplantation embryos. The authors showed that DCAF13 expression increases at the 8-cell to morula stage. Furthermore, Dcaf13 knockout (KO) caused an increase in SUV39H1 and H3K9me3 levels and developmental arrest of embryos before the morula stage. The authors thus suggested that DCAF13 regulates H3K9me3 by degrading SUV39H1 via the ubiquitin pathway and plays an important role in preimplantation development.
Although these findings suggest that the suppression of H3k9me3 by DCAF13 is required for preimplantation development, a number of studies have found that increased H3K9me3 levels during the preimplantation stage are essential for the progression of development. A genome-wide analysis of H3K9me3 by ChIP sequencing revealed that during preimplantation development, H3K9me3 increased in long terminal repeats (LTRs) which occupy a large part of the genome. The suppression of H3K9 by knockdown (KD) of CHAF1A, which can regulate SETDB1-catalyzing H3K9me3 [8] , decreased the level of H3K9me3 and caused developmental arrest at the morula stage [9] . Furthermore, KD of CAF1, a chaperone of H3.1 and H3.2 (which are enriched in H3K9me3), caused deficiencies in the formation of chromocenters (tightly packed congregations of pericentromeric heterochromatin that appear after the 2-cell stage) and developmental arrest at the morula stage [5, 10] . This again suggests that the suppression of H3K9me3 is important in regulating preimplantation development.
The discrepancy between the results of these studies, which show both decreased [7] and increased [5, 9, 10] H3K9me3 levels to be essential to preimplantation development, may be explained by the fact that SUV39H1 and SETDB1 regulate H3K9me3 modifications of different genome regions. The suppression of SUV39h1/2 degradation by depletion of DCAF13 increases the level of H3K9me3 in rDNA and certain genes during preimplantation development [7] . SETDB1 catalyzes H3K9me3 in retrotransposons, for example, LTR and long interspersed nuclear element 1, which facilitates heterochromatin formation [5, 9] . Thus, H3K9me3 levels are decreased via SUV39H1 degradation in the genome region that needs to be transcribed for preimplantation development, but increased via SETDB1 in the region that should not be transcribed (Figure 1 ). Consistent with this hypothesis, changes in H3K9me3 level by SUV39H1 and SETDB1 cause developmental arrest at different stages: increased SUV39H1 levels cause arrest before the morula stage [7] , while the suppression of SETDB1 function causes arrest at the morula stage [9] . To verify this hypothesis, a genome-wide analysis of H3K9me3 in Dcaf13 KO embryos would be useful. After the 2-cell stage (mid to late stage), the nucleosomes of retrotransposons are subject to H3K9me3 modification by SETDB1 and are agglutinated into heterochromatins, where transcription is suppressed. Meanwhile, SUV39H1 is degraded by the ubiquitin pathway, including DCAF13, so that H3K9me3 does not modify the nucleosomes of rDNA and some genes, which are thus transcribed.
